Items tagged with Vaccines

Scientists identify 'unconventional' new pathway for TB vaccines (post)

An "unconventional" immune response now identified by scientists from the Hackensack Meridian Center for Discovery and Innovation (CDI) is a potential new pathway for developing new vaccines for tuberculosis (TB), according to a new publication.

Biofabri and TBVI sign a contract with the European Health and Digital Executive Agency to accelerate the final development of the new TB vaccine MTBVAC (post)

  • Tuberculosis (TB) makes 10 million people sick every year, and kills around 1.5 million people, more than any other infectious disease.  
  • Drug resistant TB is a growing problem, with more than 400 thousand new cases annually, and more than 150 thousand deaths. 
  • MTBVAC is a highly promising TB vaccine candidate that aims to prevent both drug sensitive and drug resistant TB in infants as well as in adolescents and adults.

O Porriño, 20th June 2024. Biofabri, a global human vaccine development company that is part of the Zendal group, and TBVI, a non-profit foundation facilitating the discovery and development of new TB vaccines that are globally accessible and affordable, have signed a contract with the European Health and Digital Executive Agency (HaDEA) under the EU4Health Programme to accelerate the final development of the MTBVAC vaccine. MTBVAC is a highly promising vaccine candidate that has the potential to be used as an alternative to BCG vaccination in infants and for prevention of TB disease in adolescents and adults. 

(post with image)

Novel vaccine trial design aims to answer key TB questions (post with simple image)

Prevention of infection study underway in South Africa.

The Lancet journals: World TB Day media alert (post with simple image)

For World TB Day 2014, The Lancet group publishes a Series of papers to highlight the need for global collaboration to diagnose, treat, and cure people with tuberculosis.

HIV i-Base/TAG: 2014 Pipeline Report (post with simple image)

Latest annual review on pipeline drugs for adults and children, strategies for cure and prevention for HIV, HCV, TB and vaccine research.

New vaccine shows promise as stronger weapon against both tuberculosis and leprosy (post with simple image)

UCLA-led research finds that a variant of an existing vaccine offers stronger protection against both diseases

Large trial will evaluate vaccine’s ability to prevent tuberculosis disease (post with simple image)

Multi-site study underway in Africa

New vaccines targeting adults and teens are best chance to eliminate TB by 2050 (post with simple image)

Targets to eliminate tuberculosis by 2050 are more likely to be met if new vaccines are developed for adults and adolescents instead of for infants.

TB R&D’s shift to the left (post with simple image)

As the Bill & Melinda Gates Foundation realigns its TB vaccine strategy to focus on early-stage candidate development, equitable access priorities must also be established before large-scale trials are conducted.

Page 27 of 31 · Total posts: 0

←First 26 27 28 Last→